Literature DB >> 3422628

Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts.

E Balza1, L Borsi, G Allemanni, L Zardi.   

Abstract

Fibronectin (FN) polymorphism is caused by alternative splicing patterns in at least three regions of the primary transcript of a single gene. Using a monoclonal antibody (Mab) specific for an FN segment (ED-A), that can be included or omitted from the molecule depending on the pattern of splicing, we have examined whether transforming growth factor beta (TGF-beta) and dexamethasone, which are both known to increase the level of total FN, regulate the levels of different FN isoforms. We found that, while dexamethasone does not significantly change the ratio between the total FN and the ED-A containing FN, TGF-beta preferentially increases the expression of the FN isoform containing the ED-A sequence.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3422628     DOI: 10.1016/0014-5793(88)80580-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  48 in total

1.  Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform.

Authors:  J George; S S Wang; A M Sevcsik; M Sanicola; R L Cate; V E Koteliansky; D M Bissell
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

2.  Co-assembly of plasma and cellular fibronectins into fibrils in human fibroblast cultures.

Authors:  D M Peters; L M Portz; J Fullenwider; D F Mosher
Journal:  J Cell Biol       Date:  1990-07       Impact factor: 10.539

Review 3.  Transforming growth factor-beta in disease: the dark side of tissue repair.

Authors:  W A Border; E Ruoslahti
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

4.  Alternative splicing of endothelial cell fibronectin mRNA in the IIICS region. Functional significance.

Authors:  O Kocher; S P Kennedy; J A Madri
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

5.  Fibronectin EDA forms the chronic fibrotic scar after contusive spinal cord injury.

Authors:  John G Cooper; Su Ji Jeong; Tammy L McGuire; Sripadh Sharma; Wenxia Wang; Swati Bhattacharyya; John Varga; John A Kessler
Journal:  Neurobiol Dis       Date:  2018-04-27       Impact factor: 5.996

6.  Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.

Authors:  Shi-Ling Song; Zuo-Jiong Gong; Quan-Rong Zhang; Tuan-Xin Huang
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

7.  Type I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair.

Authors:  L I Gold; J J Sung; J W Siebert; M T Longaker
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

8.  TGF beta and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin.

Authors:  A Berndt; H Kosmehl; U Mandel; U Gabler; X Luo; D Celeda; L Zardi; D Katenkamp
Journal:  Histochem J       Date:  1995-12

9.  L-arginine may mediate the therapeutic effects of low protein diets.

Authors:  I Narita; W A Border; M Ketteler; E Ruoslahti; N A Noble
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.

Authors:  T Yamamoto; T Nakamura; N A Noble; E Ruoslahti; W A Border
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.